Items where contributor is "Lampert, Markus Leopold"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2014 | 2011 | 2010 | 2008 | 2007 | 2006


Kaufmann, Carole P. and Tremp, Regina and Hersberger, Kurt E. and Lampert, Markus L.. (2014) Inappropriate prescribing : a systematic overview of published assessment tools. European journal of clinical pharmacology, Vol. 70, H. 1. S. 1-11.

Hersberger, Kurt E. and Lampert, Markus L. and Bernnhardt, Vera. (2014) Schlüsselkompetenzen Pharmazie. In: Erfolgreich in die Zukunft. Schlüsselkompetenzen in Gesundheitsberufen. Konzepte und Praxismodelle für die Aus-, Weiter- und Fortbildung in Deutschland, Österreich und der Schweiz. Heidelberg, pp. 239-267.


Mengiardi, Seraina and Tsakiris, Dimitrios A. and Lampert, Markus L. and Hersberger, Kurt E.. (2011) Drug use problems with self-injected low-molecular-weight heparins in primary care. European journal of clinical pharmacology, Vol. 67, H. 2. S. 109-120.


Eichenberger, Patrick M. and Lampert, Markus L. and Kahmann, Irene Vogel and van Mil, J. W. Foppe and Hersberger, Kurt E.. (2010) Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharmacy world & science, Vol. 32, H. 3. S. 362-372.


Lampert, Markus L. and Kraehenbuehl, Stephan and Hug, Balthasar L.. (2008) Drug-related problems : evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharmacy world & science, Vol. 30, H. 6. S. 768-776.


Lampert, M. L. and Rätz Bravo, A. E. and Brugger, S. and Haschke, M.. (2007) Ungewöhlicher Wirkungsverlust von Oxcarbazepin. PRAXIS, 96 (47). pp. 1843-1848.

Burri, E. and Rüegg, S. and Rutishauser, J. and Egger, S. S. and Lampert, M. L.. (2007) Subtherapeutische Phenytoinspiegel infolge eines Medikationsfehlers. PRAXIS, 96 (17). pp. 687-692.


Kummer, O. and Haschke, M. and Tuchscherer, D. and Lampert, M. and Martius, F. and Krähenbühl, S.. (2006) Agranulozytose bei einem mit Metamizol und Clopidogrel behandelten Patienten. PRAXIS, 95 (45). pp. 1743-1747.